Status:
COMPLETED
Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic
Lead Sponsor:
Fatma Soliman Elsayed Ebeid, MD
Conditions:
Coronavirus COVID-19
Eligibility:
All Genders
Up to 18 years
Brief Summary
This is a prospective follow-up non-intervention study that will be carried out at Hematology/ Oncology Department, Children's hospital, Ain-Shams University, Cairo, Egypt. All followed-up children be...
Detailed Description
Study Procedures: On admission or during the outpatient visit: 1. Obtaining an informed consent . 2. Full medical history, concurrent medications, demographic data and epidemiological data (history ...
Eligibility Criteria
Inclusion
- Children below 18 years with malignancy either hematological or solid tumors or
- Children below 18 years with hematological condition
Exclusion
- 1\. Patients or care-givers refusal to be enrolled in the study
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04404244
Start Date
January 1 2020
End Date
January 1 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, Egypt, 11566